✦ LIBER ✦

TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

✍ Scribed by Stefan Verheye; Mark Webster; James Stewart; Alexandre Abizaid; Ricardo Costa; Jose Costa Jr; John Yan; vinayak bhat; lynn morrison; Sara Toyloy; John Ormiston

Book ID: 119272637
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 142 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.08.598

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CRT-4 Multi-center, First-in-man Evaluat

CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results

✍ Verheye, Stefan; Webster, Mark; Stewart, Jim; Abizaid, Alexandre; Costa, Ricardo 📂 Article 📅 2013 🏛 American College of Cardiology 🌐 English ⚖ 89 KB

TCT-610 Prospective, Multi-Center Evalua

TCT-610 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

✍ Abizaid, Alexandre; Schofer, Joachim; Maeng, Michael; Witzenbichler, Bernhard; B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 69 KB

TCT-37 Prospective, Multi-Center Evaluat

TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

✍ Abizaid, Alexandre; Schofer, Joachim; Maeng, Michael; Witzenbichler, Bernhard; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

TCT-39 6-Month Angiographic Follow-up of

TCT-39 6-Month Angiographic Follow-up of the Novel DESolveTM Myolimus-Eluting Bioresorbable Coronary Scaffold for the Treatment of Non-Complex Coronary Lesions – Results from the DESolve I First-In-Man Trial

✍ Ricardo Costa; Alexandre Abizaid; Mark Webster; James Stewart; Jose Costa Jr; ly 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

TCT-429: Single Center, First-In-Man Stu

TCT-429: Single Center, First-In-Man Study of the Elixir Novolimus Eluting Coronary Stent System with Durable Polymer 24- Month Clinical Safety and Efficacy Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 215 KB

TCT-37: ABSORB Cohort B Trial: 9 Months

TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB